Literature DB >> 28433231

Liver transplantation for acute liver failure.

Amelia J Hessheimer1, Lucas Nacif1, Eduardo Flores Villalba1, Constantino Fondevila2.   

Abstract

Before liver transplantation became widely applicable as a treatment option, the mortality rate for acute liver failure was as high as 85%. Today, acute liver failure is a relatively common transplant indication in some settings, but the results of liver transplantation in this context appear to be worse than those for chronic forms of liver disease. In this review, we discuss the indications and contraindications for urgent liver transplantation. In particular, we consider the roles of auxiliary, ABO-incompatible, and urgent living donor liver transplantation and address the management of a «status 1» patient with total hepatectomy and portocaval shunt for toxic liver syndrome.
Copyright © 2017 AEC. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  ABO-incompatible liver transplantation; Acute liver failure; Auxiliary liver transplantation; Fallo hepático agudo; Fulminant hepatitis; Hepatitis fulminante; Living donor liver transplantation; Síndrome de hígado tóxico; Toxic liver syndrome; Trasplante hepático auxiliar; Trasplante hepático con donante vivo; Trasplante hepático incompatible-ABO

Mesh:

Year:  2017        PMID: 28433231     DOI: 10.1016/j.ciresp.2017.01.008

Source DB:  PubMed          Journal:  Cir Esp        ISSN: 0009-739X            Impact factor:   1.653


  2 in total

Review 1.  Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report.

Authors:  Lucas Souto Nacif; Daniel R Waisberg; Rafael Soares Pinheiro; Fabiana Roberto Lima; Vinicius Rocha-Santos; Wellington Andraus; Luiz Carneiro D'Albuquerque
Journal:  J Med Case Rep       Date:  2018-03-10

2.  Deficiency of Ninjurin1 attenuates LPS/D-galactosamine-induced acute liver failure by reducing TNF-α-induced apoptosis in hepatocytes.

Authors:  Min Woo Kim; Ju-Hee Kang; Hyun Jin Jung; Se Yong Park; Jong-Ik Hwang; Je Kyung Seong; Yeo Sung Yoon; Seung Hyun Oh
Journal:  J Cell Mol Med       Date:  2022-09-07       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.